Skip to main content

Table 1 Mean (SD) patient age and clinical severity by type of treatments prescribed at baseline

From: Patient characteristics associated with treatment initiation among paediatric patients with Attention-Deficit/Hyperactivity Disorder symptoms in a naturalistic setting in Central Europe and East Asia

Variables

No TX

Other TX

Psycho

Pharmaco

Combi

P value

All

      

 Patient age

8.60 (2.49)

7.90 (2.14)

8.66 (2.06)

9.13 (2.61)

9.24 (2.51)

<0.001

 CGI-ADHD

4.16 (1.01)

4.33 (0.94)

4.80 (1.12)

4.51 (0.93)

4.55 (1.01)

<0.001

 CSI-4

72.63 (11.02)

73.58 (10.30)

76.31 (10.08)

75.29 (10.49)

78.65 (10.43)

<0.001

East Asia only

      

 Patient age

8.60 (2.66)

7.61 (1.98)

9.05 (2.15)

9.20 (2.58)

8.95 (2.41)

<0.001

 CGI-ADHD-S

4.01 (0.86)

4.50 (0.95)

5.23 (0.90)

4.52 (0.93)

4.65 (0.99)

<0.001

 CSI-4

71.21 (10.95)

73.22 (9.38)

76.25 (9.68)

74.61 (9.08)

73.33 (9.27)

0.022

Central Europe only

      

 Patient age

8.59 (2.32)

8.64 (2.38)

8.34 (1.95)

9.04 (2.66)

9.32 (2.54)

0.037

 CGI-ADHD-S

4.30 (1.11)

3.91 (0.75)

4.46 (1.16)

4.49 (0.93)

4.53 (1.01)

0.041

 CSI-4

73.99 (10.96)

74.50 (12.55)

76.35 (10.49)

76.25 (12.16)

80.14 (10.27)

<0.001

  1. Abbreviations: SD standard deviation, ADHD attention-deficit/hyperactivity disorder, CGI-ADHD-S Clinical Global Impressions-ADHD-Severity, CSI-4 Child Symptom Inventory-4 Parent Checklist, TX treatment, Psycho psychotherapy only, Pharmaco pharmacotherapy only, Combi the combination of both psychotherapy and pharmacotherapy.